Wisam N. Awadallah

Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia

R. Matusik, N. Miller, Wei Huang, 2020, The Prostate.

Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia

R. Matusik, N. Miller, Wei Huang, 2019, bioRxiv.

Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro

R. Matusik, P. Clark, R. A. Phillips, 2020, Molecular Cancer Therapeutics.

SLX4IP Promotes Telomere Maintenance in Androgen Receptor–Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization

Derek J. Taylor, Magdalena M. Grabowska, Wisam N. Awadallah, 2020, Molecular Cancer Research.

Increased nuclear factor I/B expression in prostate cancer correlates with AR expression

J. Mirosevich, P. Clark, J. Cates, 2019, bioRxiv.

Nuclear factor I/B increases in prostate cancer to support androgen receptor activation

J. Mirosevich, P. Clark, J. Cates, 2019 .

“IL1B loss is associated with increased AR activity in castration-resistant prostate cancer”

Magdalena M. Grabowska, J. Nanda, Wisam N. Awadallah, 2021 .

SLX4IP-mediated telomere maintenance is essential for androgen receptor-independent castration-resistant prostate cancer

Derek J. Taylor, Magdalena M. Grabowska, Wisam N. Awadallah, 2020, bioRxiv.